Author

J. Tatake

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:rat· 2

Frequent Co-Authors

A. Chakraborty· 2 shared A. Diwan· 2 shared B. Pond· 2 shared N. Holkar· 2 shared P. Holkar· 2 shared V. Arora· 2 shared V. Chiniga· 2 shared Y. Thakur· 2 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

A. Chakraborty

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual Effects of NV-CoV-2 Biomimetic Polymer: An Antiviral regimen against COVID-19

A. Chakraborty, A. Diwan, V. Chiniga, V. Arora, P. Holkar, Y. Thakur, J. Tatake, R. Barton, N. Holkar, B. Pond

This paper evaluates NV-CoV-2 polymer and its encapsulation of remdesivir (NV-CoV-2-R) for antiviral efficacy against COVID-19, showing improved stability and effectiveness compared to remdesivir alone.

bioRxiv · Nov 24, 2021 · PreprintPharmacology & Toxicology

Nanoviricides platform technology based NV-CoV-2 polymer increases the half-life of Remdesivir in vivo

A. Chakraborty, A. Diwan, V. Arora, Y. Thakur, V. Chiniga, J. Tatake, P. Holkar, N. Holkar, B. Pond

This paper reports on a non-clinical study of NV-CoV-2 polymer and its encapsulation of Remdesivir, showing improved in vivo stability and safety in rats.

bioRxiv · Nov 17, 2021 · PreprintPharmacology & Toxicology